ATE395330T1 - Verfahren zur herstellung von (-)-(s)-3-(1- (dimethylamino)ethyl) phenyl-n-ethyl-n- methylcarbamat - Google Patents

Verfahren zur herstellung von (-)-(s)-3-(1- (dimethylamino)ethyl) phenyl-n-ethyl-n- methylcarbamat

Info

Publication number
ATE395330T1
ATE395330T1 AT03769173T AT03769173T ATE395330T1 AT E395330 T1 ATE395330 T1 AT E395330T1 AT 03769173 T AT03769173 T AT 03769173T AT 03769173 T AT03769173 T AT 03769173T AT E395330 T1 ATE395330 T1 AT E395330T1
Authority
AT
Austria
Prior art keywords
ethyl
carbamat
dimethylamino
phenyl
methyl
Prior art date
Application number
AT03769173T
Other languages
English (en)
Inventor
Hana Stepankova
Josef Hajicek
Stanislav Simek
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE395330T1 publication Critical patent/ATE395330T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/50—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03769173T 2002-10-24 2003-10-21 Verfahren zur herstellung von (-)-(s)-3-(1- (dimethylamino)ethyl) phenyl-n-ethyl-n- methylcarbamat ATE395330T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20023555A CZ293014B6 (cs) 2002-10-24 2002-10-24 Způsob výroby (-)-(S)-3-[1-(dimethylamino)ethyl]fenyl-N-ethyl-N-methylkarbamátu

Publications (1)

Publication Number Publication Date
ATE395330T1 true ATE395330T1 (de) 2008-05-15

Family

ID=29751096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769173T ATE395330T1 (de) 2002-10-24 2003-10-21 Verfahren zur herstellung von (-)-(s)-3-(1- (dimethylamino)ethyl) phenyl-n-ethyl-n- methylcarbamat

Country Status (9)

Country Link
US (1) US7544840B2 (de)
EP (1) EP1556338B1 (de)
AT (1) ATE395330T1 (de)
AU (1) AU2003277795A1 (de)
CZ (1) CZ293014B6 (de)
DE (1) DE60321030D1 (de)
EA (1) EA006967B1 (de)
UA (1) UA79972C2 (de)
WO (1) WO2004037771A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2409453A (en) 2003-12-24 2005-06-29 Generics Process for the preparation of aminoalkyl phenylcarbamates
ES2615487T3 (es) * 2004-11-08 2017-06-07 Emcure Pharmaceuticals Limited un método eficaz para la preparación de (S)-3-[(1-dimetilamino)etil]-fenil-N-etil-N-metil-carbamato
KR20060072326A (ko) * 2004-12-23 2006-06-28 동국제약 주식회사 페닐카바메이트 유도체의 새로운 합성 방법
ES2267399B1 (es) * 2005-08-04 2008-02-01 Ragactives, S.L. Procedimiento para la obtencion de carbamatos de fenilo.
CN100391938C (zh) * 2005-09-02 2008-06-04 上海奥博生物医药技术有限公司 (s)-n-乙基-n-甲基-3-[1-(二甲氨基)乙基]-氨基甲酸苯酯(ⅰ)及其酒石酸盐(ⅱ)的制备方法
US7767843B2 (en) 2006-03-02 2010-08-03 Apotex Pharmachem Inc. Process for the preparation of phenylcarbamates
CA2661009A1 (en) * 2006-08-17 2008-02-21 Alembic Limited Improved process for the preparation of rivastigmine
WO2008037433A1 (en) 2006-09-29 2008-04-03 Synthon B.V. Process for making aminoalkylphenyl carbamates and intermediates therefor
EP1942100A1 (de) * 2007-01-04 2008-07-09 Krka Tovarna Zdravil, D.D., Novo Mesto Amorphe und kristalline Formen von Rivastigminhydrogentartrat
WO2008110339A2 (en) * 2007-03-09 2008-09-18 Synthon B.V. Polymorphs of rivastigmine hydrogentartrate
EP1980552A3 (de) 2007-04-10 2008-10-29 Dr. Reddy's Laboratories Ltd. Verfahren zur Herstellung von Rivastigmin oder einem Salz daraus
US7884121B2 (en) 2007-06-11 2011-02-08 Apotex Pharmachem Inc. Process for the preparation of phenylcarbamates
WO2009086705A1 (zh) 2008-01-10 2009-07-16 Shanghai Institute Of Pharmaceutical Industry 利凡斯的明的制备方法、其中间体以及中间体的制备方法
EP2349976B1 (de) 2008-08-25 2012-12-26 Jubilant Life Sciences Limited Verfahren zur herstellung von (s)-3-[(1-dimethylamino)ethyl]phenyl-n-ethyl-n- methylcarbamat über neue zwischenprodukte
CN101823970B (zh) * 2009-03-03 2013-05-08 江苏恩华药业股份有限公司 卡巴拉汀及其中间体的合成方法
CN101580482B (zh) * 2009-05-27 2014-04-23 沈阳药科大学 一种重酒石酸盐卡巴拉汀的制备方法和应用
CN101613292B (zh) * 2009-07-29 2013-05-22 上海医药集团股份有限公司 (s)-3-(1-二甲氨基乙基)苯酚的制备方法
WO2011070585A1 (en) * 2009-10-28 2011-06-16 Shodhana Laboratories Limited Processes for preparing rivastigmine, salts and intermediates thereof
WO2011151669A1 (en) 2010-06-02 2011-12-08 Jubilant Life Sciences Limited Process for producing enantiomerically enriched isomer of 3-(1-aminoethyl) phenyl derivative and employing the same to produce rivastigmine or its pharmaceutically acceptable salt
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DK2582799T3 (en) 2010-06-17 2018-02-12 Codexis Inc BIOCATALATORS AND PROCEDURES FOR THE SYNTHESIS OF (S) -3- (1-AMINOETHYL) -PHENOL
CN102786441B (zh) 2011-05-18 2013-11-13 浙江海正药业股份有限公司 利凡斯的明的制备方法、其中间体以及中间体的制备方法
CN102285904B (zh) * 2011-07-11 2013-06-05 中国科学院成都生物研究所 一种卡巴拉汀的制备方法
CN102898333A (zh) * 2012-10-22 2013-01-30 哈药集团三精制药股份有限公司 一种重酒石酸卡巴拉汀的制备方法
CN103896787A (zh) * 2012-12-26 2014-07-02 江苏康倍得药业有限公司 一种卡巴拉汀前体[1-(3-甲氧基苯基)乙基]二甲胺的制备方法
CN105254513A (zh) * 2015-10-29 2016-01-20 无锡福祈制药有限公司 (s)-3-[1-(二甲基氨基)乙基]苯酚(ⅲ)的拆分方法
CN106565543B (zh) * 2016-10-14 2018-06-22 昆明源瑞制药有限公司 一种重酒石酸卡巴拉汀的制备方法
CN109507345B (zh) * 2017-09-15 2022-08-05 万特制药(海南)有限公司 重酒石酸卡巴拉汀中间体及其杂质的分离测定方法
KR20200035359A (ko) 2018-09-26 2020-04-03 캐딜라 파마슈티클즈 리미티드 리바스티그민 제조용 중간체의 합성
CN113461554A (zh) * 2020-03-30 2021-10-01 北京泰德制药股份有限公司 一种卡巴拉汀中间体的纯化方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
HU201906B (en) 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU2003277795A1 (en) 2004-05-13
EP1556338A1 (de) 2005-07-27
EP1556338B1 (de) 2008-05-14
CZ20023555A3 (cs) 2004-01-14
EA200500049A1 (ru) 2005-06-30
CZ293014B6 (cs) 2004-01-14
UA79972C2 (uk) 2007-08-10
DE60321030D1 (de) 2008-06-26
EA006967B1 (ru) 2006-06-30
US20060122417A1 (en) 2006-06-08
WO2004037771A1 (en) 2004-05-06
US7544840B2 (en) 2009-06-09

Similar Documents

Publication Publication Date Title
ATE395330T1 (de) Verfahren zur herstellung von (-)-(s)-3-(1- (dimethylamino)ethyl) phenyl-n-ethyl-n- methylcarbamat
DE60212193D1 (de) Verfahren zur verbesserung der reproduktionsleistung bei geflügel
ATE452882T1 (de) Herstellung von quetiapin
ATE316075T1 (de) Verfahren zur monomethylierung von stickstoffhaltigen heterocyclen
ATE317387T1 (de) Verfahren zur herstellung von intermediaten für pestizide
ATE388957T1 (de) Herstellung von siliziumverbrückten metallocenverbindungen
ATE387425T1 (de) Verfahren zur herstellung von bicalutamid
DE60105314D1 (de) Verfahren zur herstellung von taxanderivaten
ATE277887T1 (de) Verfahren zur herstellung von 1,4-bis((2- (dimethylamino)ethyl amino)-5,8- dihydroxyanthracene-9,10-dion
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE462687T1 (de) Verfahren zur herstellung von azoverbindungen
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE60234279D1 (de) Verfahren zur herstellung eines immunosuppresivums
ATE280769T1 (de) Verfahren zur herstellung von vitronectin- rezeptorantagonisten
ATE469141T1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
ATE528358T1 (de) Verfahren zur herstellung einer azoverbindung
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
ATE380183T1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
DE602005001507D1 (de) Verfahren zur herstellung von diiminverbindungen
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
ATE299147T1 (de) Verfahren zur herstellung von 3-amino-1,5- benzodiazepinderivaten
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties